Carrier-Mediated Delivery of 9-(2-Phosphonylmethoxyethyl)Adenine to Parenchymal Liver Cells: a Novel Therapeutic Approach for Hepatitis B

Our aim is to selectively deliver 9-(2-phosphonylmethoxyethyl)adenine (PMEA) to parenchymal liver cells, the primary site of hepatitis B virus (HBV) infection. Selective delivery is necessary because PMEA, which is effective against HBV in vitro, is hardly taken up by the liver in vivo. Lactosylated...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	de Vrueh, Remco L. A., Rump, Erik T., van de Bilt, Erika, van Veghel, Richard, Balzarini, Jan, Biessen, Erik A. L., van Berkel, Theo J. C., Bijsterbosch, Martin K.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2000
Matèries:	Pharmacology
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89714/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10681306/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.3.477-483.2000
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!